Access cutting-edge light chain amyloidosis treatment through this clinical trial at a research site in Scottsdale. Study-provided care at no cost to qualified participants.
Access light chain amyloidosis specialists in Scottsdale at no cost
This study follows strict safety protocols and ethical guidelines
All study-related light chain amyloidosis treatment provided free
This phase II trial compares shorter-duration versus longer-duration maintenance therapy with daratumumab for improving survival in patients who have received initial treatment with daratumumab for light chain (AL) amyloidosis. Maintenance therapy is treatment that is given to help keep cancer from coming back after it has disappeared following initial therapy. Daratumumab is in a class of medications called monoclonal antibodies. It binds to a protein called CD38, which is found on some types o
Sponsor: Mayo Clinic
Check if you qualify for this light chain amyloidosis clinical trial in Scottsdale, AZ
If you're searching for light chain amyloidosis treatment options in Scottsdale, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Scottsdale research site is actively enrolling participants for this clinical trial. You'll receive care from experienced light chain amyloidosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.